Rajeev Shah Sells 1M Prelude Therapeutics Shares
Ticker: PRLD · Form: 4 · Filed: Apr 28, 2026 · CIK: 0001678660
| Field | Detail |
|---|---|
| Company | Prelude Therapeutics Inc (PRLD) |
| Form Type | 4 |
| Filed Date | Apr 28, 2026 |
| Risk Level | medium |
| Sentiment | bearish |
Sentiment: bearish
Topics: insider-sale, disposition, form-4
Related Tickers: PRLD
TL;DR
Rajeev Shah dumped 1M $PRLD shares at $1.00 on 4/27.
AI Summary
On April 27, 2026, Rajeev M. Shah reported a disposition of 1,000,000 shares of Prelude Therapeutics Inc. common stock. The transaction was executed at an average price of $1.00 per share, resulting in a total value of $1,000,000. This filing was made on April 28, 2026.
Why It Matters
This Form 4 filing indicates a significant sale of stock by a key individual, which could signal a change in their outlook on the company's future performance.
Risk Assessment
Risk Level: medium — A large insider sale can sometimes indicate a lack of confidence in the company's future prospects, warranting a medium risk assessment.
Key Numbers
- 1,000,000 — Shares Sold (Significant disposition by reporting person.)
- $1.00 — Price Per Share (Average price at which shares were sold.)
- $1,000,000 — Total Value (Aggregate value of the stock sale.)
Key Players & Entities
- Rajeev M. Shah (person) — Reporting Person
- Prelude Therapeutics Inc. (company) — Issuer
- 1,000,000 shares (dollar_amount) — Number of shares disposed
- $1.00 (dollar_amount) — Price per share
- $1,000,000 (dollar_amount) — Total transaction value
- 2026-04-27 (date) — Date of transaction
- 2026-04-28 (date) — Filing date
FAQ
Who is Rajeev M. Shah in relation to Prelude Therapeutics Inc.?
Rajeev M. Shah is listed as a Reporting Person for Prelude Therapeutics Inc. and has a business address at 175 Innovation Boulevard, Wilmington, DE.
What type of transaction is reported in this Form 4?
This Form 4 reports a disposition of securities, specifically the sale of common stock.
When did the reported stock transaction occur?
The transaction occurred on April 27, 2026.
What was the total value of the shares sold by Rajeev M. Shah?
The total value of the shares sold was $1,000,000, based on 1,000,000 shares sold at an average price of $1.00 per share.
What is the filing date for this Form 4?
The filing date for this Form 4 is April 28, 2026.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 28, 2026 by Rajeev M. Shah regarding Prelude Therapeutics Inc (PRLD). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.